M. Smalley, L. Piggott, and R. Clarkson, Breast cancer stem cells: Obstacles to therapy, Cancer Letters, vol.338, issue.1, pp.57-62, 2013.
DOI : 10.1016/j.canlet.2012.04.023

S. Mani, W. Guo, M. Liao, E. Eaton, A. Ayyanan et al., The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells, Cell, vol.133, issue.4, pp.704-715, 2008.
DOI : 10.1016/j.cell.2008.03.027

V. Battula, Y. Shi, K. Evans, R. Wang, E. Spaeth et al., Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis, Journal of Clinical Investigation, vol.122, issue.6, pp.2066-2078, 2012.
DOI : 10.1172/JCI59735DS1

URL : http://www.jci.org/articles/view/59735/files/pdf

B. Hollier, A. Tinnirello, S. Werden, K. Evans, J. Taube et al., FOXC2 Expression Links Epithelial-Mesenchymal Transition and Stem Cell Properties in Breast Cancer, Cancer Research, vol.73, issue.6, pp.1981-1992, 2013.
DOI : 10.1158/0008-5472.CAN-12-2962

URL : http://cancerres.aacrjournals.org/content/canres/73/6/1981.full.pdf

C. June, B. Blazar, and J. Riley, Engineering lymphocyte subsets: tools, trials and tribulations, Nature Reviews Immunology, vol.112, issue.10, pp.704-716, 2009.
DOI : 10.4049/jimmunol.172.1.104

URL : http://europepmc.org/articles/pmc3412112?pdf=render

N. Restifo, M. Dudley, and S. Rosenberg, Adoptive immunotherapy for cancer: harnessing the T cell response, Nature Reviews Immunology, vol.3, issue.4, pp.269-281, 2012.
DOI : 10.1126/scitranslmed.3002949

S. Rosenberg and N. Restifo, Adoptive cell transfer as personalized immunotherapy for human cancer, Science, vol.385, issue.224, pp.62-68, 2015.
DOI : 10.1016/S0140-6736(14)61403-3

C. Riganti, M. Massaia, M. Davey, and M. Eberl, Human ???? T-cell responses in infection and immunotherapy: Common mechanisms, common mediators?, European Journal of Immunology, vol.22, issue.7, pp.1668-1676, 2012.
DOI : 10.1016/j.smim.2010.04.004

URL : http://onlinelibrary.wiley.com/doi/10.1002/eji.201242492/pdf

J. Fournié, H. Sicard, M. Poupot, C. Bezombes, A. Blanc et al., What lessons can be learned from ???? T cell-based cancer immunotherapy trials?, Cellular & Molecular Immunology, vol.8, issue.1, pp.35-41, 2013.
DOI : 10.1038/nrclinonc.2010.223

J. Fisher, J. Heuijerjans, M. Yan, K. Gustafsson, and J. Anderson, ???? T cells for cancer immunotherapy, OncoImmunology, vol.154, issue.1, p.27572, 2014.
DOI : 10.1158/0008-5472.CAN-10-3862

B. Silva-santos, K. Serre, and H. Norell, ???? T cells in cancer, Nature Reviews Immunology, vol.45, issue.11, pp.683-691, 2015.
DOI : 10.1016/0092-8674(86)90388-0

M. Todaro, D. Asaro, M. Caccamo, N. Iovino, F. Francipane et al., Efficient Killing of Human Colon Cancer Stem Cells by ???? T Lymphocytes, The Journal of Immunology, vol.182, issue.11, pp.7287-7296, 2009.
DOI : 10.4049/jimmunol.0804288

URL : http://www.jimmunol.org/content/jimmunol/182/11/7287.full.pdf

D. Lai, F. Wang, Y. Chen, C. Wang, S. Liu et al., Human ovarian cancer stem-like cells can be efficiently killed by ???? T lymphocytes, Cancer Immunology, Immunotherapy, vol.31, issue.2, pp.979-989, 2012.
DOI : 10.1002/eji.201041282

N. Nishio, M. Fujita, Y. Tanaka, H. Maki, R. Zhang et al., Zoledronate Sensitizes Neuroblastoma-derived Tumor-initiating Cells to Cytolysis Mediated by Human ???? T Cells, Journal of Immunotherapy, vol.35, issue.8, pp.598-606, 2012.
DOI : 10.1097/CJI.0b013e31826a745a

J. Li, M. Herold, B. Kimmel, I. Muller, B. Rincon-orozco et al., Reduced Expression of the Mevalonate Pathway Enzyme Farnesyl Pyrophosphate Synthase Unveils Recognition of Tumor Cells by V??9V??2 T Cells, The Journal of Immunology, vol.182, issue.12, pp.8118-8124, 2009.
DOI : 10.4049/jimmunol.0900101

F. Navid, P. Sondel, R. Barfield, B. Shulkin, R. Kaufman et al., Phase I Trial of a Novel Anti-GD2 Monoclonal Antibody, Hu14.18K322A, Designed to Decrease Toxicity in Children With Refractory or Recurrent Neuroblastoma, Journal of Clinical Oncology, vol.32, issue.14, pp.1445-1452, 2014.
DOI : 10.1200/JCO.2013.50.4423

B. Elenbaas, L. Spirio, F. Koerner, M. Fleming, D. Zimonjic et al., Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells, Genes & Development, vol.15, issue.1, pp.50-65, 2001.
DOI : 10.1101/gad.828901

URL : http://genesdev.cshlp.org/content/15/1/50.full.pdf

Y. Liang, Y. Ding, S. Levery, M. Lobaton, K. Handa et al., Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells, Proceedings of the National Academy of Sciences, vol.203, issue.3, pp.4968-4973, 2013.
DOI : 10.1111/j.1432-1033.1992.tb16586.x

T. Schatton and M. Frank, Antitumor Immunity and Cancer Stem Cells, Annals of the New York Academy of Sciences, vol.278, issue.1, pp.154-169, 2009.
DOI : 10.4049/jimmunol.174.5.2591

Y. Gao, Y. W. Pan, M. Scully, E. Girardi, M. Augenlicht et al., ???? T Cells Provide an Early Source of Interferon ?? in Tumor Immunity, The Journal of Experimental Medicine, vol.65, issue.3, pp.433-442, 2003.
DOI : 10.1084/jem.183.4.1681

URL : http://jem.rupress.org/content/jem/198/3/433.full.pdf

J. Welton, M. Morgan, S. Martí, M. Stone, B. Moser et al., Monocytes and ???? T cells control the acute-phase response to intravenous zoledronate: Insights from a phase IV safety trial, Journal of Bone and Mineral Research, vol.19, issue.11, pp.464-471, 2013.
DOI : 10.1007/s00262-011-1049-8

URL : http://onlinelibrary.wiley.com/doi/10.1002/jbmr.1797/pdf

D. Rhodes, H. Chen, A. Price, A. Keeble, M. Davey et al., Activation of Human ???? T Cells by Cytosolic Interactions of BTN3A1 with Soluble Phosphoantigens and the Cytoskeletal Adaptor Periplakin, The Journal of Immunology, vol.194, issue.5, pp.2390-2398, 2015.
DOI : 10.4049/jimmunol.1401064

V. Lafont, J. Liautard, J. Liautard, and J. Favero, Production of TNF-?? by Human V??9V??2 T Cells Via Engagement of Fc??RIIIA, the Low Affinity Type 3 Receptor for the Fc Portion of IgG, Expressed upon TCR Activation by Nonpeptidic Antigen, The Journal of Immunology, vol.166, issue.12, pp.7190-7199, 2001.
DOI : 10.4049/jimmunol.166.12.7190

J. Gertner-dardenne, C. Bonnafous, C. Bezombes, A. Capietto, V. Scaglione et al., Bromohydrin pyrophosphate enhances antibody-dependent cell-mediated cytotoxicity induced by therapeutic antibodies, Blood, vol.113, issue.20, pp.4875-4884, 2009.
DOI : 10.1182/blood-2008-08-172296

URL : http://www.bloodjournal.org/content/bloodjournal/113/20/4875.full.pdf

A. Capietto, L. Martinet, and J. Fournie, Stimulated ???? T Cells Increase the In Vivo Efficacy of Trastuzumab in HER-2+ Breast Cancer, The Journal of Immunology, vol.187, issue.2, pp.1031-1038, 2011.
DOI : 10.4049/jimmunol.1100681

M. Vesely, M. Kershaw, R. Schreiber, and M. Smyth, Natural Innate and Adaptive Immunity to Cancer, Annual Review of Immunology, vol.29, issue.1, pp.235-271, 2011.
DOI : 10.1146/annurev-immunol-031210-101324

J. Yang and S. Rosenberg, Adoptive T-Cell Therapy for Cancer, Adv Immunol, vol.130, pp.279-294, 2016.
DOI : 10.1016/bs.ai.2015.12.006

C. June, S. Riddell, and T. Schumacher, Adoptive cellular therapy: A race to the finish line, Science Translational Medicine, vol.7, issue.280, pp.280-287, 2015.
DOI : 10.1158/0008-5472.CAN-11-2837

T. Schatton, U. Schutte, N. Frank, Q. Zhan, A. Hoerning et al., Modulation of T-Cell Activation by Malignant Melanoma Initiating Cells, Cancer Research, vol.70, issue.2, pp.697-708, 2010.
DOI : 10.1158/0008-5472.CAN-09-1592

URL : http://cancerres.aacrjournals.org/content/canres/70/2/697.full.pdf

D. Tomaso, T. Mazzoleni, S. Wang, E. Sovena, G. Clavenna et al., Immunobiological Characterization of Cancer Stem Cells Isolated from Glioblastoma Patients, Clinical Cancer Research, vol.16, issue.3, pp.800-813, 2010.
DOI : 10.1158/1078-0432.CCR-09-2730

H. Chen, A. Chou, Y. Liu, C. Hsieh, C. Kang et al., Induction of metastatic cancer stem cells from the NK/LAK-resistant floating, but not adherent, subset of the UP-LN1 carcinoma cell line by IFN-??, Laboratory Investigation, vol.26, issue.10, pp.1502-1513, 2011.
DOI : 10.1007/s10555-010-9233-4

R. Tallerico, M. Todaro, D. Franco, S. Maccalli, C. Garofalo et al., Human NK Cells Selective Targeting of Colon Cancer-Initiating Cells: A Role for Natural Cytotoxicity Receptors and MHC Class I Molecules, The Journal of Immunology, vol.190, issue.5, pp.2381-2390, 2013.
DOI : 10.4049/jimmunol.1201542

URL : http://www.jimmunol.org/content/jimmunol/190/5/2381.full.pdf

C. , S. R. Martinez, C. Aguilar, B. , D. Apuzzo et al., Recognition and killing of brain tumor stem-like initiating cells by CD8 + cytolytic T cells, Cancer Res, vol.69, pp.8886-8893, 2009.

T. Liao, A. Kaufmann, X. Qian, V. Sangvatanakul, C. Chen et al., Susceptibility to cytotoxic T cell lysis of cancer stem cells derived from cervical and head and neck tumor cell lines, Journal of Cancer Research and Clinical Oncology, vol.2, issue.4, pp.159-170, 2013.
DOI : 10.1097/00008571-199208000-00001

C. Visus, Y. Wang, A. Lozano-leon, R. Ferris, S. Silver et al., Targeting ALDHbright Human Carcinoma-Initiating Cells with ALDH1A1-Specific CD8+ T Cells, Clinical Cancer Research, vol.17, issue.19, pp.6174-6184, 2011.
DOI : 10.1158/1078-0432.CCR-11-1111

URL : http://clincancerres.aacrjournals.org/content/clincanres/17/19/6174.full.pdf

P. Hadji, R. Coleman, C. Wilson, T. Powles, P. Clézardin et al., Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel, Annals of Oncology, vol.31, issue.(Suppl 1), pp.379-390, 2016.
DOI : 10.1158/0008-5472.CAN-10-3862

URL : https://academic.oup.com/annonc/article-pdf/27/3/379/16700079/mdv617.pdf

V. Kunzmann and M. Wilhelm, Adjuvant zoledronic acid for breast cancer: mechanism of action?, The Lancet Oncology, vol.12, issue.11, pp.991-992, 2011.
DOI : 10.1016/S1470-2045(11)70252-2

J. Welton, S. Martí, M. Mahdi, C. Boobier, P. Barrett-lee et al., ???? T Cells Predict Outcome in Zoledronate-Treated Breast Cancer Patients, The Oncologist, vol.18, issue.8, pp.22-23, 2013.
DOI : 10.1634/theoncologist.2013-0097

URL : http://theoncologist.alphamedpress.org/content/18/8/e22.full.pdf

H. Chen, F. Dieli, and M. Eberl, An unconventional TRAIL to cancer therapy, European Journal of Immunology, vol.8, issue.12, pp.3159-3162, 2013.
DOI : 10.1371/journal.pone.0051805

URL : http://onlinelibrary.wiley.com/doi/10.1002/eji.201344105/pdf

U. Jarry, C. Chauvin, N. Joalland, A. Léger, S. Minault et al., Stereotaxic administrations of allogeneic human V??9V??2 T cells efficiently control the development of human glioblastoma brain tumors, OncoImmunology, vol.28, issue.5, p.1168554, 2016.
DOI : 10.18632/oncotarget.1201

M. Ahmed, J. Hu, and N. Cheung, Structure Based Refinement of a Humanized Monoclonal Antibody That Targets Tumor Antigen Disialoganglioside GD2, Frontiers in Immunology, vol.25, issue.1, p.372, 2014.
DOI : 10.1093/protein/gzr053

URL : http://journal.frontiersin.org/article/10.3389/fimmu.2014.00372/pdf

N. Himoudi, D. Morgenstern, M. Yan, B. Vernay, L. Saraiva et al., Human ???? T Lymphocytes Are Licensed for Professional Antigen Presentation by Interaction with Opsonized Target Cells, The Journal of Immunology, vol.188, issue.4, pp.1708-1716, 2012.
DOI : 10.4049/jimmunol.1102654

URL : http://www.jimmunol.org/content/jimmunol/188/4/1708.full.pdf

H. Korkaya and M. Wicha, HER2 and Breast Cancer Stem Cells: More than Meets the Eye, Cancer Research, vol.73, issue.12, pp.3489-3493, 2013.
DOI : 10.1158/0008-5472.CAN-13-0260

URL : http://cancerres.aacrjournals.org/content/canres/73/12/3489.full.pdf

K. Moynihan, C. Opel, G. Szeto, A. Tzeng, E. Zhu et al., Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses, Nature Medicine, vol.13, issue.12, pp.1402-1410, 2016.
DOI : 10.1016/j.immuni.2015.08.006

URL : http://europepmc.org/articles/pmc5209798?pdf=render

M. Brandes, K. Willimann, G. Bioley, N. Levy, M. Eberl et al., Cross-presenting human ???? T cells induce robust CD8+ ???? T cell responses, Proceedings of the National Academy of Sciences, vol.215, issue.1, pp.2307-2312, 2009.
DOI : 10.1111/j.1600-065X.2006.00472.x

URL : http://www.pnas.org/content/106/7/2307.full.pdf

S. Meuter, M. Eberl, and B. Moser, Prolonged antigen survival and cytosolic export in cross-presenting human ???? T cells, Proceedings of the National Academy of Sciences, vol.187, issue.10, pp.8730-8735, 2010.
DOI : 10.1084/jem.187.10.1583

URL : http://www.pnas.org/content/107/19/8730.full.pdf

M. Khan, S. Curbishley, H. Chen, A. Thomas, H. Pircher et al., Expanded human blood-derived ?? T cells display potent antigen-presentation functions, Front Immunol, vol.5, p.344, 2014.
DOI : 10.3389/fimmu.2014.00344

URL : http://journal.frontiersin.org/article/10.3389/fimmu.2014.00344/pdf

L. Piggott, N. Omidvar, M. Perez, S. French, R. Eberl et al., Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL, Breast Cancer Research, vol.82, issue.Suppl 1, p.88, 2011.
DOI : 10.1002/jnr.20629

M. Herold, J. Van-den-brandt, J. Seibler, and H. Reichardt, Inducible and reversible gene silencing by stable integration of an shRNA-encoding lentivirus in transgenic rats, Proceedings of the National Academy of Sciences, vol.23, issue.4, pp.18507-18512, 2008.
DOI : 10.1159/000221981